AF
ABCL icon

Aviso Financial’s AbCellera Biologics ABCL Stock Holding History

Aviso Financial’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.8K Hold
6,540
– – ﹤0.01% 267
2025
Q4 		$22.4K Hold
6,540
– – ﹤0.01% 261
2025
Q3 		$32.9K Hold
6,540
– – ﹤0.01% 256
2025
Q2 		$22.4K Hold
6,540
– – ﹤0.01% 265
2025
Q1 		$14.6K Hold
6,540
– – ﹤0.01% 278
2024
Q4 		$19.2K Hold
6,540
– – ﹤0.01% 282
2024
Q3 		$17K Buy
+6,540
New +$18.1K ﹤0.01% 294

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aviso Financial's ABCL Position: Q1 2026 in Review

Aviso Financial held its AbCellera Biologics (ABCL) position steady in Q1 2026 at 6,540 shares worth $22.8K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Aviso Financial first reported a position in ABCL in Q3 2024 and has held it in 7 quarters since. The position peaked at $32.9K in Q3 2025. 138 funds tracked by Wall St. Rank hold ABCL as of Q1 2026.

  • Aviso Financial held 6,540 shares of AbCellera Biologics worth $22.8K as of Q1 2026.
  • Aviso Financial left its AbCellera Biologics share count unchanged in Q1 2026.
  • AbCellera Biologics made up ﹤0.01% of Aviso Financial's portfolio in Q1 2026, its #267 holding.
  • Aviso Financial first reported a position in AbCellera Biologics in Q3 2024 and has held it in 7 quarters since.
  • Aviso Financial's AbCellera Biologics position peaked at $32.9K in Q3 2025.
  • 138 funds tracked by Wall St. Rank held AbCellera Biologics as of Q1 2026.

Based on Aviso Financial's 13F filing for Q1 2026, filed 14 May 2026.